Get The Alerts + Report

AGIOS PHARMACEUTICALS, INC. [AGIO]

Reporting date: 10/08/2025

⚠️ Neutral Insider Mix Detected

📝 What Happened

  • Insider: Scadden David
  • Role: Director
  • Company: AGIOS PHARMACEUTICALS, INC. (AGIO)
  • Transaction Date(s): 2025-10-08
  • Table I (Non-Derivative Securities)
    • Sale : 200
    • Average Sale Price: $41.00
    • Total Value: $8,200.00
    • Post-Transaction Direct Holdings: 17,603
    • Indirect Holdings: 0
    • 10b5-1 Plan Used? Yes

📄 Summary

Scadden David, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), mixed 400 shares (200 acquired, 200 sold) on October 08, 2025, at an average price of $29.55, realizing proceeds of about ~$8,200.00. After the transaction, he now holds 17,603 direct shares and 0 indirect shares. For retail traders, this is a neutral event: routine option exercise and sale under a 10b5-1 plan, likely profit-taking.

🔑 Interpretation

  • Type: Comp-related (exercise and sale executed under a Rule 10b5-1 trading plan)
  • Disposition: Shares acquired via option exercise were sold immediately (same-day disposition)
  • Size Context: The sale of 200 shares is small relative to his post-transaction direct holding (~17,603 shares) — consistent with routine profit-taking, not a large liquidation
  • ATH Metric: Using recent price context (yesterday's close as a reference), the $41 sale price does not appear to be at an extreme all-time high or low for the stock; the transaction does not clearly coincide with an ATH or ATL and therefore does not look opportunistically timed to an all-time extreme
  • Outlier Check: Not unusually large compared to typical single-insider option exercises/sales; appears routine

📊 Bullish or Bearish?

Neutral

Neutral. The filing shows a simultaneous option exercise and sale of the same number of shares under a 10b5-1 plan (codes M and S), yielding modest proceeds — a typical, planned liquidity event rather than a signal of declining conviction. Data completeness is sufficient for this single-insider event, but cluster activity cannot be determined from this filing alone.

✅ Bottom Line (Retail Takeaway)

This transaction looks like routine profit-taking rather than a bearish signal. For retail traders, it’s noise, not a tradeable event — not worth short-/mid-term action unless corroborated by sales from multiple senior insiders.